Clinically, miR-107 is significantly downregulated in ESCC tissues (particularly advanced stages), correlating with poor differentiation, lymph node metastasis, and adverse prognosis—a pattern reinforced by rescue experiments showing TPM3 overexpression reverses miR-107–mediated suppression. Here, TPM3 is linked to esophageal squamous cell carcinoma.